Executive Function Support.

Caffeine blocks adenosine A1 and A2A receptors, which is the settled explanation for its effect on subjective alertness and on sustained attention task performance. Task performance is an outcome, not a marker, in trials that measure it directly. It is the most consistently measured single input in this category.

Theanine is structurally close to glutamate and interacts with glutamate transport and receptor systems, and it is combined with caffeine specifically to alter the felt quality of caffeine's effect. The pairing has been examined in attention-task settings more often than most nutrient combinations. The mechanism side remains better described than the size of the effect.

Docosahexaenoic acid is enriched in neuronal and synaptic membrane phospholipids and influences membrane fluidity, which is established lipid biochemistry. Supplementation trials on cognitive endpoints in healthy adults have been mixed, and a null result there is a failure to detect a difference rather than proof of none. Membrane structure is the honest claim.

DHA rather than EPA is the fatty acid concentrated in brain phospholipids, so DHA-weighted products are used where neural membrane composition is the stated interest. The structural role is settled. Cognitive endpoint results across trials remain inconsistent.

Choline acetyltransferase joins choline and acetyl-CoA to make acetylcholine, the transmitter of the cholinergic attention systems, and that step is textbook. Supplying substrate is not the same as raising transmission, which depends on neuronal firing. State the precursor relationship and stop there.

Cytidine diphosphocholine is an intermediate of phosphatidylcholine synthesis, so it supplies material for both membrane phospholipid and acetylcholine formation. The biochemistry is settled. It is the reason citicoline appears in attention-directed formulas rather than plain choline salts.

Alpha-glycerophosphocholine is hydrolysed to free choline and glycerophosphate, adding to the choline pool available for acetylcholine and phospholipid synthesis. The conversion step is established. It sits alongside citicoline as a formulation choice rather than above it.

Methylcobalamin is the cofactor that lets methionine synthase remethylate homocysteine to methionine, the precursor of S-adenosylmethionine and therefore of most methylation reactions in the brain. That dependency is textbook. Homocysteine is a marker, and an association between it and cognitive test scores is not a causal demonstration.

5-methyltetrahydrofolate hands its methyl group to cobalamin at methionine synthase, so folate and B12 are functionally coupled and a shortfall in either stalls the cycle. This is settled biochemistry. It explains why the two are formulated together rather than alone.

Pyridoxal 5-phosphate is required by aromatic L-amino acid decarboxylase and by glutamate decarboxylase, the enzymes producing the monoamine and GABA transmitters. The cofactor requirement is textbook. Cofactor sufficiency permits synthesis; it does not by itself increase transmitter output.

Tyrosine hydroxylase is a non-heme iron enzyme, so iron status constrains the rate-limiting step of catecholamine production. That dependency is established biochemistry and is why iron status is checked before attributing attention complaints to anything else. Iron above requirement has no established further effect on this step.

Vesicular zinc is released with glutamate at hippocampal synapses and modulates NMDA receptor responses, an established feature of that circuitry. Zinc is also a structural and catalytic cofactor across metabolism. Adequacy matters; excess does not add to the mechanism.

The voltage-dependent magnesium block of the NMDA receptor is the property that makes that receptor a coincidence detector in synaptic plasticity, which is textbook neurophysiology. Whether oral magnesium changes brain magnesium enough to shift that behaviour is a separate and less settled question. Keep the two statements apart.

Creatine kinase regenerates ATP from phosphocreatine wherever demand is spiky, and brain tissue carries the system as well as muscle. Human work on cognitive endpoints has focused on sleep-deprived and low-intake states. The bioenergetic role is well established; the endpoint effect in rested, well-fed adults is not.

Bacopa is one of the few botanicals in this category with several randomised trials using standardised memory tasks, generally over multi-week dosing rather than acutely. It is combined with acute-acting inputs like caffeine for that reason. The effect sizes reported are modest.

Rhodiola has been examined in trials using workload and fatigue endpoints in students and shift workers. Results vary with extract and dose, and the mechanism is not settled. It is placed in blends as a fatigue-facing input rather than an attention-facing one.

Tyrosine hydroxylase converts tyrosine to L-DOPA and then to dopamine and noradrenaline, so tyrosine is the substrate for the whole catecholamine branch. Supplying substrate matters most where turnover is already high, such as under acute stress or cold, which is where most of the human work sits. Substrate supply is not the same as increased release.

Phosphatidylserine is concentrated on the cytoplasmic face of neuronal membranes and participates in signalling protein docking, which is established cell biology. Human supplementation work on cognitive endpoints is limited and heterogeneous. Formulas include it on the membrane rationale.

A 2026 randomised report in Neuropsychopharmacology Reports examined probiotic supplementation against executive-function measures in a paediatric clinical population, which is a narrow group and not a general claim. Gut bacteria produce short-chain fatty acids and neuroactive metabolites, which is the mechanistic rationale. The evidence is early and population-specific.

Ginkgo extracts have been examined in many trials with mixed results on cognitive test batteries in healthy adults. The flavone glycoside and terpene lactone fractions are the standardised markers. Include it as a widely used input with an inconsistent literature rather than a settled one.

Hericenones and erinacines from Hericium erinaceus stimulate nerve growth factor expression in cell culture, which is a laboratory finding rather than a human outcome. A small number of human trials exist and are short and small. Read the rationale as preclinical.

The acetyl group on acetyl-L-carnitine can be transferred to coenzyme A and used in acetylcholine formation, and carnitine itself carries fatty acids into mitochondria. Both steps are established biochemistry. Human cognitive-endpoint work is mostly in older adults and is not uniform.

Calcitriol acts through a nuclear receptor that is expressed in brain tissue, and observational cohorts report associations between vitamin D status and cognitive test performance. An association is not a cause, and supplementation trials on those endpoints have been inconsistent. Correcting a shortfall is the defensible framing.

A 2026 scoping review in the American Journal of Clinical Nutrition mapped human trials of nutritional strategies aimed at glucose metabolism against cognitive-ageing endpoints, a mapping exercise rather than an efficacy verdict. Cinnamon sits in that class of inputs. The link is a rationale, not a demonstrated cognitive effect.